Federal Register of Legislation - Australian Government

Primary content

Determinations/Health as made
This instrument amends item 72814 of the Health Insurance (Section 3C Co-Dependent Pathology Services) Determination 2018 to allow people who have been diagnosed with recurrent (not amenable to local treatment) or metastatic squamous cell carcinoma of the oral cavity, pharynx or larynx to access the pembrolizumab on the Pharmaceutical Benefits Scheme.
Administered by: Health and Aged Care
Registered 26 Sep 2022
Tabling HistoryDate
Tabled HR27-Sep-2022
Tabled Senate28-Sep-2022
To be repealed 09 Feb 2023
Repealed by Division 1 of Part 3 of Chapter 3 of the Legislation Act 2003
Table of contents.

Commonwealth Coat of Arms of Australia

 

Health Insurance (Section 3C Co-Dependent Pathology Services) Amendment Determination (No. 5) 2022

I, Nigel Murray, delegate of the Minister for Health and Aged Care, make the following Determination.

Dated               23 September 2022

Nigel Murray

Assistant Secretary
MBS Policy and Specialist Services

Medical Benefits Division

Department of Health and Aged Care

 

 

 


Contents

1  Name........................................................................................................................................ 1

2  Commencement........................................................................................................................ 1

3  Authority.................................................................................................................................. 1

4  Schedules................................................................................................................................. 1

Schedule 1— Amendments                                                                                          2

Health Insurance (Section 3C Co-Dependent Pathology Services) Determination 2018       2

 

 


1  Name

                        This instrument is the Health Insurance (Section 3C Co-Dependent Pathology Services) Amendment Determination (No. 5) 2022.

2  Commencement

(1)       Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

 

Commencement information

Column 1

Column 2

Column 3

Provisions

Commencement

Date/Details

1.  The whole of this instrument

1 October 2022.

 

                Note:        This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

(2)       Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

                        This instrument is made under subsection 3C(1) of the Health Insurance Act 1973.

4  Schedules

                        Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.


 

Schedule 1— Amendments

Health Insurance (Section 3C Co-Dependent Pathology Services) Determination 2018

1      Schedule 1 (item 72814)

Following “cancer”, insert “or recurrent or metastatic squamous cell carcinoma of the oral cavity, pharynx or larynx”